Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Fixed Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.880.800.811.131.32

What is the latest Fixed Capital/Sales ratio of NATCO PHARMA ?

The latest Fixed Capital/Sales ratio of NATCO PHARMA is 0.88 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.88
Mar20250.80
Mar20240.81
Mar20231.13
Mar20221.32

How is Fixed Capital/Sales of NATCO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.88
10.00
Mar2025 0.8
-1.23
Mar2024 0.81
-28.32
Mar2023 1.13
-14.39
Mar2022 1.32 -

Other Financial Ratios of NATCO PHARMA


Compare Fixed Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,406.6 Cr -1.9% -2.7% -6.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.9%

-2.7%

-6.3%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses